NVST - Envista Holdings Corporation

NYSE - NYSE Delayed price. Currency in USD

Envista Holdings Corporation

Building E
200 South Kraemer Boulevard
Brea, CA 92821-6208
United States
714 817 7000

IndustryMedical Instruments & Supplies
Full-time employees12,700

Key executives

NameTitlePayExercisedYear born
Mr. Amir AghdaeiPres, CEO & Director3.42M7.78M1959
Mr. Howard H. YuSr. VP & CFO842.14k697.82k1973
Mr. Mark E. NanceSr. VP, Gen. Counsel & Sec.753.64kN/A1969
Mr. Patrik ErikssonSr. VP & Pres of Nobel Biocare834.61kN/A1968
Mr. Jean-Claude E. KyrillosSr. VP and Pres of Diagnostics & Digital Solutions814kN/A1964
Stephen KellerVP of Investor RelationsN/AN/AN/A
Juan ArbonaChief Compliance OfficerN/AN/AN/A
Mr. Mischa M. ReisSr. VP of Strategy & Corp. Devel.N/AN/A1973
Mr. Filippo ImpieriSr. VP of Emerging MarketsN/AN/AN/A
Ms. Claudia OrtizSr. VP of Regulatory Affairs & Quality AssuranceN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Corporate governance

Envista Holdings Corporation’s ISS governance QualityScore as of 1 June 2023 is 4. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.